We are Sorry, This Page doesn't Exist

Cambridge biotech startup grabs $65M to tackle liver disease

A newly launched biotech company has secured $65 million in financing as it seeks to develop the first-ever treatment for a disorder that its co-founder described as “the life being squeezed out of the liver.” Cambridge-based Akero Therapeutics is fo.....»»

Category: topSource: bizjournalsJun 25th, 2018

Alzheimer’s Disease Symptoms Reversed in Flies by Balancing Enzymes

This finding could pave the wave for Alzheimer's treatment and biomarkers for early diagnosis......»»

Category: topSource: newsweekMay 15th, 2018

IPO News This Week: Two Solid Offerings on Tap

The two IPOs on this week's calendar include one tech unicorn and a biotech working on a treatment from Alzheimer disease......»»

Category: blogSource: 247wallstApr 8th, 2018

States Where Alzheimer’s Causes the Most Deaths

Alzheimer’s disease, which destroys memory and important mental functions over time, and for which there is no cure, is the sixth leading cause of death in the United States. Worldwide,........»»

Category: blogSource: 247wallst1 min. ago

Alzheimer’s Warning Signs, Do Not Ignore Them!

Alzheimer’s Warning Signs, Do Not Ignore Them! Like any other disease, early detection plays a Key role in getting the right help at the right time for Alzheimer’s disease. To ensure early dete.....»»

Category: topSource: livetradingnewsNov 9th, 2018

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes......»»

Category: blogSource: 247wallstNov 8th, 2018

Artificial Intelligence Can Predict Alzheimer’s Faster Than Previously Thought

Alzheimer’s disease is one of the most difficult brain disorders, and many fear they will suffer from it eventually. However, researchers now believe artificial .....»»

Category: blogSource: valuewalkNov 8th, 2018

The Keto Diet Fights: Obesity, Diabetes, Heart Disease and Alzheimer’s

The Keto Diet Fights: Obesity, Diabetes, Heart Disease and Alzheimer’s The 1 diet is being praised by leading health experts as an effective tool in battling the epidemics of obesity, diabetes, and heart disease......»»

Category: topSource: livetradingnewsNov 5th, 2018

Regenxbio Treatment of CLN2 disease granted orphan designation

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 26th, 2018

Clinical Trials on Alzheimer"s Disease to hold a meeting

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Retired Supreme Court Justice Sandra Day O’Connor Reveals She Has Dementia

“As this condition has progressed, I am no longer able to participate in public life." Retired U.S. Supreme Court Justice Sandra Day O'Connor says she has been diagnosed with dementia, probably Alzheimer's disease, and is.....»»

Category: europeSource: fortuneOct 23rd, 2018

Meet Ionis Pharma’s Newest Collaboration

Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases......»»

Category: blogSource: 247wallstOct 10th, 2018

Cambridge"s Akcea rebounds with FDA approval of first drug

After having one of its drugs rejected by the FDA in August, Cambridge biotech Akcea Therapeutics Inc. turned the tide on Friday, receiving approval for another treatment for a rare genetic disease. The FDA approved Tegsedi, known generically as ino.....»»

Category: topSource: bizjournalsOct 5th, 2018

Genentech"s first scientist now focused on Bay Area"s latest biotech IPO

A South San Francisco company in a race to come up with a treatment for a deadly liver disease wants to raise $75 million in an initial public offering. NGM Biopharmaceuticals Inc. — backed by the venture capital firm managed by Dave Goeddel, the fi.....»»

Category: topSource: bizjournalsOct 1st, 2018

Insmed (INSM) Wins FDA Nod for Lung Disease Drug Arikayce

Insmed's (INSM) lung infection drug Arikayce gains an accelerated approval from the FDA for the treatment of lung .....»»

Category: personnelSource: nytOct 1st, 2018

Nationwide Children"s gene therapy spinoff acquired for $100M

Yet another gene therapy spinoff from Nationwide Children's Hospital has been acquired for $100 million. Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of spee.....»»

Category: topSource: bizjournalsSep 21st, 2018

CDC: Alzheimer’s, Dementia Rate To Double By 2060

The study was released the day before World Alzheimer's Day 2018. The number of people with Alzheimer’s and related dementias will double by 2060, the U.S. Centers for Disease Control and Prevention (CDC).....»»

Category: europeSource: fortuneSep 20th, 2018

Cellectar stock surges 15% premarket after FDA fast tracks treatment for rare childhood cancer

Cellectar Biosciences Inc. said Monday it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for a treatment for a rare kind of cancer in children cal.....»»

Category: topSource: marketwatchSep 17th, 2018

Acorda"s stock plunges after disappointing ruling regarding patents for Parkinson"s treatment

Shares of Acorda Therapeutics Inc. plunged 21% toward an 8-month low in midday trade Monday, after a disappointing ruling a federal appeals court on patents pertaining to its Parkinson's disease treatment, Ampy.....»»

Category: topSource: marketwatchSep 10th, 2018

States Where Alzheimer’s is Soaring

About every minute, someone in the United States develops Alzheimer’s disease. By 2050, someone will develop dementia from the illness every 33 seconds. Alzheimer’s is the most common cause of........»»

Category: blogSource: 247wallstSep 6th, 2018